Fred P. Lampropoulos has significant holdings in Merit Medical Systems inc, which are reflective of the company's growth trajectory. In 2023, he received stock options and other equity awards valued at approximately $2.77 million, which aligns with his $10 million...
Fred P. Lampropoulos has significant holdings in Merit Medical Systems inc, which are reflective of the company's growth trajectory. In 2023, he received stock options and other equity awards valued at approximately $2.77 million, which aligns with his $10 million total compensation for the year. His holdings have remained a substantial part of his wealth; in 2016, he was valued at $1.32 million in stock options alone. Over the years, there have been increases in his stock positions, reflecting the company's performance and his influence in the executive role. His wealth in Merit Medical's stock primarily showcases the alignment of leadership actions with shareholder interests. The CEO's stock activities depict both strategic investments in the company and a commitment to its future success.